Severe refractory atopic dermatitis in an adolescent patient successfully treated with ustekinumab.

Received May 30, 2012, Revised July 11, 2012, Accepted for publication September 20, 2012 Corresponding author: Francesc Messeguer, Deparment of Dermatology, Instituto Valenciano de Oncologia, Mateo Pueyo nr.6, 5 CP:46800, Xativa-Valencia, Spain. Tel: 34-685-529-231, Fax: 34-961-114-342, E-mail: francescmb@comv.es This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Fig. 1. Patient lesions in January 2011, erythematous scaly plaques over 80% of her total body surface (SCORing atopic dermatitis [SCORAD]: 23). Severe Refractory Atopic Dermatitis in an Adolescent Patient Successfully Treated with Ustekinumab